Page last updated: 2024-08-18

isomethyleugenol and Pneumonia, Viral

isomethyleugenol has been researched along with Pneumonia, Viral in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	6 (85.71)	2.80

Authors

Authors	Studies
Li, H; Li, Y; Zhou, L	1
Encinar, JA; Menendez, JA	1
Han, Q; Hoffman, RM	1
Ahmed-Belkacem, R; Canard, B; Debart, F; Decroly, E; Guiraud, M; Sutto-Ortiz, P; Vasseur, JJ	1
Goyal, A; Kumar, S; Morla, S; Sharma, K	1
Brunzelle, J; Inniss, NL; Kiryukhina, O; Minasov, G; Rosas-Lemus, M; Satchell, KJF; Shuvalova, L	1
Hancock, GE; Heers, KM; Ibraghimov, AR; Pryharski, KS; Scheuer, CA; Smith, JD	1

Reviews

1 review(s) available for isomethyleugenol and Pneumonia, Viral

Article	Year
Oral Methioninase for Covid-19 Methionine-restriction Therapy. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl Topics: Administration, Oral; Antiviral Agents; Bacterial Proteins; Betacoronavirus; Carbon-Sulfur Lyases; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Humans; Lymphocyte Activation; Macrophage Activation; Meta-Analysis as Topic; Methionine; Methylation; Pandemics; Pneumonia, Viral; Pseudomonas putida; Recombinant Proteins; RNA Caps; RNA Processing, Post-Transcriptional; RNA, Viral; S-Adenosylmethionine; SARS-CoV-2; T-Lymphocyte Subsets; Virus Replication	2020

Article

Year

Oral Methioninase for Covid-19 Methionine-restriction Therapy.

In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl

Topics: Administration, Oral; Antiviral Agents; Bacterial Proteins; Betacoronavirus; Carbon-Sulfur Lyases; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Humans; Lymphocyte Activation; Macrophage Activation; Meta-Analysis as Topic; Methionine; Methylation; Pandemics; Pneumonia, Viral; Pseudomonas putida; Recombinant Proteins; RNA Caps; RNA Processing, Post-Transcriptional; RNA, Viral; S-Adenosylmethionine; SARS-CoV-2; T-Lymphocyte Subsets; Virus Replication

2020

Other Studies

6 other study(ies) available for isomethyleugenol and Pneumonia, Viral

Article	Year
EZH2-mediated H3K27me3 inhibits ACE2 expression. Biochemical and biophysical research communications, 2020, 06-11, Volume: 526, Issue:4 Topics: Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Embryonic Stem Cells; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation; Gene Knockout Techniques; Histone Code; Histones; Humans; Lysine; Methylation; Mice; Organ Specificity; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Promoter Regions, Genetic; SARS-CoV-2; Transcription, Genetic; Up-Regulation	2020
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. Viruses, 2020, 05-10, Volume: 12, Issue:5 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Immune Evasion; Immunity, Innate; Methylation; Models, Molecular; Pandemics; Pneumonia, Viral; RNA Processing, Post-Transcriptional; RNA, Viral; SARS-CoV-2	2020
Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase. European journal of medicinal chemistry, 2020, Sep-01, Volume: 201 Topics: Adenine; Betacoronavirus; Coronavirus Infections; COVID-19; Exoribonucleases; Humans; Methylation; Methyltransferases; Molecular Docking Simulation; Nucleosides; Pandemics; Pneumonia, Viral; RNA Caps; RNA, Viral; S-Adenosylmethionine; SARS-CoV-2; Viral Nonstructural Proteins	2020
Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2. Life sciences, 2020, Oct-15, Volume: 259 Topics: Antiviral Agents; Betacoronavirus; Computational Biology; Coronavirus Infections; COVID-19; Drug Repositioning; Enzyme Inhibitors; Humans; Methylation; Methyltransferases; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sequence Homology, Amino Acid	2020
High-resolution structures of the SARS-CoV-2 2'- Science signaling, 2020, 09-29, Volume: 13, Issue:651 Topics: Adenosine; Betacoronavirus; Binding Sites; Catalytic Domain; Coronavirus Infections; COVID-19; Crystallography, X-Ray; Dimerization; Genes, Viral; Humans; Methylation; Methyltransferases; Models, Molecular; Open Reading Frames; Pandemics; Pneumonia, Viral; Protein Binding; Protein Conformation; RNA Cap Analogs; RNA Processing, Post-Transcriptional; RNA, Viral; S-Adenosylhomocysteine; S-Adenosylmethionine; SARS-CoV-2; Structure-Activity Relationship; Viral Nonstructural Proteins	2020
CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV). Vaccine, 2001, Sep-14, Volume: 19, Issue:32 Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Antibody Specificity; CpG Islands; Dimerization; Female; Immunity, Cellular; Immunoglobulin G; Injections, Intramuscular; Interferon-gamma; Interleukin-12; Interleukin-5; Killer Cells, Natural; Lung; Methylation; Mice; Mice, Inbred BALB C; Mice, Knockout; Pneumonia, Viral; Protein Subunits; Pulmonary Eosinophilia; Rats; Rats, Sprague-Dawley; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Viruses; Spleen; Vaccination; Viral Proteins	2001